Related Experiment Video
Updated: Jun 16, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Compound Heterozygous Sickle Cell-Beta Thalassemia Presenting As Chronic Hemolytic Anemia With Microcytosis and
Vijay Krishnan Radhakrishnan1, Aswanaa Kamanuru Govindarajulu1, Thilakavathi N Rajendran1
1Internal Medicine, Sri Lalithambigai Medical College and Hospital, Chennai, IND.
Sickle cell-beta thalassemia, a compound heterozygous hemoglobinopathy, can be difficult to diagnose because clinical features and laboratory findings often overlap with other hematological disorders. We report a 26-year-old man from Assam who presented with eight days of progressive jaundice. Further evaluation revealed chronic hemolysis that had gone undiagnosed for years. He also reported one week of abdominal distension and generalized weakness. Clinical examination revealed pallor, icterus, and moderate splenomegaly. Laboratory evaluation demonstrated anemia (hemoglobin 6.3-7.9 g/dL), microcytosis, elevated lactate dehydrogenase, indirect hyperbilirubinemia, low serum haptoglobin, moderate splenomegaly and reticulocytosis, consistent with ongoing hemolysis. The direct Coombs test was negative, ruling out immune-mediated hemolysis. Infectious causes, including chronic malaria, were excluded, and serological tests for HIV, hepatitis B, and hepatitis C were negative. Blood and urine cultures showed no growth. Glucose-6-phosphate dehydrogenase (G6PD) levels and iron studies were within normal limits, excluding enzymopathy and iron deficiency. Hemoglobin analysis revealed hemoglobin S (HbS) 73.1%, fetal hemoglobin (HbF) 15%, hemoglobin A2 (HbA2) 6.3%, and reduced hemoglobin A (HbA), consistent with compound heterozygous sickle cell-beta thalassemia. Echocardiography demonstrated prominent left ventricular apical trabeculations, likely representing adaptive cardiac remodeling in response to a chronic high-output state. This case illustrates how systematic workup can identify compound hemoglobinopathies in patients with atypical presentations. The finding of HbS-β thalassemia in a patient from Assam is epidemiologically significant, as this compound hemoglobinopathy is extremely rare in this region, where HbE variants predominate. The cardiac findings might reflect cardiovascular changes from chronic, untreated anemia.
Sickle cell-beta thalassemia, a compound heterozygous hemoglobinopathy, can be difficult to diagnose because clinical features and laboratory findings often overlap with other hematological disorders. We report a 26-year-old man from Assam who presented with eight days of progressive jaundice. Further evaluation revealed chronic hemolysis that had gone undiagnosed for years. He also reported one week of abdominal distension and generalized weakness. Clinical examination revealed pallor, icterus, and moderate splenomegaly. Laboratory evaluation demonstrated anemia (hemoglobin 6.3-7.9 g/dL), microcytosis, elevated lactate dehydrogenase, indirect hyperbilirubinemia, low serum haptoglobin, moderate splenomegaly and reticulocytosis, consistent with ongoing hemolysis. The direct Coombs test was negative, ruling out immune-mediated hemolysis. Infectious causes, including chronic malaria, were excluded, and serological tests for HIV, hepatitis B, and hepatitis C were negative. Blood and urine cultures showed no growth. Glucose-6-phosphate dehydrogenase (G6PD) levels and iron studies were within normal limits, excluding enzymopathy and iron deficiency. Hemoglobin analysis revealed hemoglobin S (HbS) 73.1%, fetal hemoglobin (HbF) 15%, hemoglobin A2 (HbA2) 6.3%, and reduced hemoglobin A (HbA), consistent with compound heterozygous sickle cell-beta thalassemia. Echocardiography demonstrated prominent left ventricular apical trabeculations, likely representing adaptive cardiac remodeling in response to a chronic high-output state. This case illustrates how systematic workup can identify compound hemoglobinopathies in patients with atypical presentations. The finding of HbS-β thalassemia in a patient from Assam is epidemiologically significant, as this compound hemoglobinopathy is extremely rare in this region, where HbE variants predominate. The cardiac findings might reflect cardiovascular changes from chronic, untreated anemia.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Multiple Allele Traits
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy II: Dilated Cardiomyopathy
